Takeda to create up to 70 new jobs in Dublin
Written by Robert McHugh
Reposted by InterSearch Ireland
It was announced yesterday that Takeda Pharmaceutical Company Limited is to create up to 70 new jobs and invest €25m in the construction of a new regenerative medicine facility at its site in Grange Castle.
The largest pharmaceutical company in Japan, Takeda first set up operations in Ireland in 1997 manufacturing products for global markets. In 2002 Takeda chose Dublin as the location for its first active pharmaceutical ingredient (API) facility outside of Japan.
In 2017, Takeda also announced a €40m investment in the construction of a stand-alone production facility for the manufacture of part of their Oncology portfolio at Grange Castle.
The investment by Takeda will expand their Grange Castle site’s existing footprint, with the construction of a new standalone modular cell therapy facility dedicated to manufacturing a novel stem cell therapy. The investment will also create 70 temporary construction jobs. The facility will be in commercial operation by 2021.
Welcoming the announcement yesterday, Minister of State, Pat Breen said, "The pharma industry makes a huge contribution to the Irish economy in terms of jobs and exports, and is one of the fastest growing sectors. Takeda's decision to invest in Ireland is a great win and vote of confidence in Ireland and it builds on our ongoing expansion of the sector here. I'm delighted that this investment will bring a further 70 jobs to the company's existing Clondalkin facility."